SCHEMBL4734066

SCHEMBL4734066

CNC1CCC(Cc2cc(-c3cccnc3F)ccc2OC)(C(N)=O)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.39
BACE1 P56817 5/20 0.36
CTSD P07339 3/20 0.36
BACE2 Q9Y5Z0 1/20 0.36
CYP2C19 P33261 1/20 0.36
GRIA2 P42262 1/20 0.36
DYRK1A Q13627 2/20 0.35
WNT1 P04628 1/20 0.35
MLNR O43193 1/20 0.35
LIPG Q9Y5X9 2/20 0.35
ABL1 P00519 1/20 0.34
ITGA4 P13612 1/20 0.34
ITGB7 P26010 1/20 0.34
CALCRL Q16602 1/20 0.34
PTGS2 P35354 1/20 0.34
LRRK2 Q5S007 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4734543 0.85 GSK3B (0.36) GSK3BABL1CALCRLKDM4EALDH1A1
SCHEMBL4730306 0.84 ROCK1 (0.39) GSK3BDYRK1ALIPGABL1
Hydrochloric Acid SCHEMBL4731120 0.84 PDE4A (0.39) GSK3BDYRK1AABL1CALCRLKDM4E
SCHEMBL4731161 0.84 PDE4B (0.40) GSK3BGRIA2DYRK1AABL1
SCHEMBL4896277 0.82 TACR1 (0.40) GSK3BMEN1KMT2A
Hydrochloric Acid SCHEMBL4783964 0.82 HTR2C (0.40) ABL1ALDH1A1HTTL3MBTL1
Hydrochloric Acid SCHEMBL4732440 0.82 MKNK1 (0.47)
Hydrochloric Acid SCHEMBL4732760 0.82 TACR1 (0.39) GSK3BMEN1KMT2A
Hydrochloric Acid SCHEMBL4731746 0.81 AR (0.37) KDM4EMEN1ALDH1A1KMT2AL3MBTL1
Hydrochloric Acid SCHEMBL4732641 0.81 HTR2C (0.39) CALCRLKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed
WO-2007089669-A2 PROCESSES FOR THE PREPARATION OF COMPOUNDS WHICH MODULATE CELL PROLIFERATION WYETH (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO GSK3B 657/4885BACE1 3120/4885CTSD 3855/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX GSK3B 527/4885BACE1 887/4885CTSD 298/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO GSK3B 657/4885BACE1 3120/4885CTSD 3855/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO GSK3B 524/4885BACE1 13/4885CTSD 2525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.